Tekla Capital Management’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	$1.42M	Hold	78,529	–	–	0.06%	123
2023 Q1	$1.26M	Buy	78,529 +32,668	+71%	+$525K	0.05%	134
2022 Q4	$839K	Buy	+45,861	New	+$839K	0.03%	136